English
|
正體中文
|
简体中文
|
Items with full text/Total items : 12145/12927 (94%)
Visitors : 848277 Online Users : 931
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by
NTU Library IR team.
Scope
All of NHRI
癌症研究所
劉滄梧
--期刊論文
--會議論文/會議摘要
Tips:
please add "double quotation mark" for query phrases to get precise results
please goto advance search for comprehansive author search
Adv. Search
Home
‧
Login
‧
Upload
‧
Help
‧
About
‧
Administer
國家衛生研究院 NHRI
>
癌症研究所
>
劉滄梧
>
Browse By Title
Browse By Authors
Browse By Date
Browse By Data Type
Community Detail
Introduction:
NA
Loading...
Collection
期刊論文
[
100
/101]
會議論文/會議摘要
[
19
/24]
Siblings
于重元
[
19
/19]
劉柯俊
[
85
/98]
劉界元(2003-2010)
[
3
/3]
夏和雄(1996-2012)
[
26
/31]
夏興國
[
51
/54]
姜乃榕
[
82
/94]
常慧如
[
39
/44]
張俊彥
[
234
/254]
張光裕
[
69
/79]
張憶壽
[
103
/106]
張文祥
[
52
/53]
張書銘
[
89
/91]
彭汪嘉康(1996-2007)
[
120
/126]
施能耀
[
37
/43]
李家惠
[
29
/29]
李岳倫
[
48
/49]
林素芳
[
32
/32]
楊奕馨
[
41
/42]
江士昇
[
88
/90]
沈哲宏
[
14
/16]
洪文俊
[
88
/88]
莊雙恩
[
82
/91]
蔡坤志
[
32
/34]
蔡慧珍
[
66
/71]
蘇勇曄
[
40
/40]
蘇振良
[
24
/25]
郭靜娟
[
71
/76]
陳尚鴻
[
45
/48]
陳振陽
[
72
/72]
陳立宗
[
443
/510]
陳美霞(2002-2009)
[
1
/1]
陳詩政
[
2
/2]
陳雅雯
[
38
/39]
黃智興
[
55
/55]
黃道揚
[
26
/26]
丁兆治(2000-2004)
[
5
/5]
其他
[
464
/471]
劉敏(1996-2007)
[
60
/62]
劉玫英(2004-2006)
[
2
/2]
吳成文(1996-2008)
[
53
/55]
曾思文(1997-2007)
[
4
/4]
李冠德(1997-2004)
[
4
/6]
林景太(1999-2007)
[
5
/5]
楊文光(1996-1999)
[
21
/21]
王全正(1996-2003)
[
4
/4]
莊聲宏(1997-2004)
[
11
/11]
詹宗晃(2000-2008)
[
2
/2]
賴基銘(2004-2008)
[
41
/47]
阮麗蓉(2000-2006)
[
6
/7]
陳俊叡(2003-2007)
[
6
/6]
馬彥英(1997-1999)
[
1
/1]
黃奇英(2005-2007)
[
9
/10]
Community Statistics
近3年內發表的文件:16(12.80%)
含全文筆數:119(95.20%)
文件下載次數統計
下載大於0次:119(100.00%)
下載大於100次:114(95.80%)
檔案下載總次數:64106(1.20%)
最後更新時間: 2024-11-28 03:53
Top Upload
Loading...
Top Download
Loading...
Recent Submissions
Taiwan nationwide study of first-li...
Survival of advanced/recurrent gast...
Impact of pathological nodal stagin...
Prevalence of comorbidities and the...
Association of smoking and ALK tyro...
Carbohydrate antigen 19-9 response ...
Adjuvant chemotherapy compared with...
Secular trends of clinical characte...
Optimizing margin status for improv...
Overall survival in the OlympiA pha...
Jump to a point in the index:
(Choose year)
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
1995
1994
1993
1992
1991
1990
1985
1980
1975
1970
1960
1950
(Choose month)
January
February
March
April
May
June
July
August
September
October
November
December
Or type in a year:
Ordering With Most Recent First
Show Oldest First
Showing items 1-10 of 125. (13 Page(s) Totally)
1
2
3
4
5
6
7
8
9
10
>
>>
View [
10
|
25
|
50
] records per page
Date
Title
Relation
2024-10-11
Taiwan nationwide study of first-line ALK-TKI therapy in ALK-positive lung adenocarcinoma
Targeted Oncology. 2024 Oct 11;Article in Press.
2024-07-11
Survival of advanced/recurrent gastrointestinal stromal tumors treated with tyrosine kinase inhibitors in Taiwan: A nationwide registry study
BMC Cancer. 2024 Jul 11;24:Article number 828.
2023-10
Impact of pathological nodal staging and tumour differentiation on survival and postoperative radiotherapy in completely resected stage IIIA Non-small-cell lung cancer
Lung Cancer. 2023 Oct;184:Article number 107357.
2023-09
Carbohydrate antigen 19-9 response to initial adjuvant chemotherapy predicts survival and failure pattern of resected pancreatic adenocarcinoma but not which patients are suited for additional adjuvant chemoradiation therapy: From a prospective randomized study
International Journal of Radiation Oncology Biology Physics. 2023 Sep 1;117(1):74-86.
2023-04-25
Prevalence of comorbidities and their impact on survival among older adults with the five most common cancers in Taiwan: a population study
Scientific Reports. 2023 Apr 25;13:Article number 6727.
2023-03-17
Association of smoking and ALK tyrosine-kinase inhibitors on overall survival in treatment-naive ALK-positive advanced lung adenocarcinoma
Frontiers in Oncology. 2023 Mar 17;13:Article number 1063695.
2023-02-28
Adjuvant chemotherapy compared with observation in patients with T2aN0 stage IB lung adenocarcinoma
Frontiers in Oncology. 2023 Feb 28;13:Article number 1096683.
2022-12-31
Secular trends of clinical characteristics and survival of hepatocellular carcinoma in Taiwan from 2011 to 2019
Viruses. 2022 Dec 31;15(1):Article number 126.
2022-12
Recalibrating risk prediction models by synthesizing data sources: Adapting the lung cancer PLCO model for Taiwan
Cancer Epidemiology, Biomarkers and Prevention. 2022 Dec 5;31(12):2208-2218.
2022-12
Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high risk, early breast cancer
Annals of Oncology. 2022 Dec;33(12):1250-1268.
Showing items 1-10 of 125. (13 Page(s) Totally)
1
2
3
4
5
6
7
8
9
10
>
>>
View [
10
|
25
|
50
] records per page
DSpace Software
Copyright © 2002-2004
MIT
&
Hewlett-Packard
/
Enhanced by
NTU Library IR team
Copyright ©
-
Feedback